Chemours Co
$ 14.80
1.44%
11 Aug - close price
- Market Cap 2,370,359,000 USD
- Current Price $ 14.80
- High / Low $ 15.28 / 14.64
- Stock P/E N/A
- Book Value -0.33
- EPS -2.02
- Next Earning Report -
- Dividend Per Share $0.35
- Dividend Yield 2.32 %
- Next Dividend Date -
- ROA 0.01 %
- ROE -3.19 %
- 52 Week High 28.57
- 52 Week Low 10.35
About
The Chemours Company offers high performance chemicals in North America, Asia Pacific, Europe, the Middle East, Africa and Latin America. The company is headquartered in Wilmington, Delaware.
Analyst Target Price
$23.22
Quarterly Earnings
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-08-04 | 2026-05-05 | 2026-02-19 | 2025-11-06 | 2025-08-05 | 2025-05-06 | 2025-02-18 | 2024-11-04 | 2024-08-01 | 2024-04-30 | 2024-03-27 | 2023-10-26 |
| Reported EPS | 0.42 | 0.05 | 0.05 | 0.2 | 0.58 | 0.13 | 0.11 | 0.4 | 0.38 | 0.32 | 0.31 | 0.63 |
| Estimated EPS | 0.43 | 0.2036 | 0.02 | 0.24 | 0.46 | 0.2 | 0.16 | 0.28 | 0.58 | 0.17 | 0.25 | 0.69 |
| Surprise | -0.01 | -0.1536 | 0.03 | -0.04 | 0.12 | -0.07 | -0.05 | 0.12 | -0.2 | 0.15 | 0.06 | -0.06 |
| Surprise Percentage | -2.3256% | -75.442% | 150% | -16.6667% | 26.087% | -35% | -31.25% | 42.8571% | -34.4828% | 88.2353% | 24% | -8.6957% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Previous Dividend Records
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2026-09-15 | 2026-06-16 | 2026-03-13 | 2025-12-15 | 2025-09-12 | 2025-06-16 | 2025-03-14 | 2024-12-16 | 2024-09-13 | 2024-06-14 |
| Amount | $0.0875 | $0.0875 | $0.0875 | $0.0875 | $0.0875 | $0.0875 | $0.25 | $0.25 | $0.25 | $0.25 |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: CC
2026-08-11 20:10:42
Chemours Co director Mary B. Cranston purchased 6,000 shares of common stock at $15.825 per share on August 7, 2026, in an open-market transaction. Following this purchase, her beneficial ownership of Chemours common stock increased to 113,140.9469 shares, which includes directly owned shares, restricted stock units, and dividend equivalent units. The transaction is detailed in a Form 4 SEC filing, indicating a positive sentiment for the company's stock.
2026-08-11 13:39:42
Chemours has introduced two new low-GWP refrigerants, Opteon ZE and Opteon 515B, designed for data center chillers and other large-scale cooling applications. These products aim to provide environmentally friendly alternatives for companies transitioning from higher global warming potential refrigerants. The company emphasizes the importance of these solutions in meeting the evolving cooling demands of AI and data center infrastructure while ensuring efficiency and regulatory compliance.
2026-08-11 12:39:42
Chemours (CC) stock saw movement after reporting a narrower net loss of $274 million in Q2, an improvement from the previous year, despite missing adjusted earnings and revenue estimates. The company's segment results were mixed, with growth in Titanium Technologies and Performance Solutions (driven by AI infrastructure demand), but declines in Thermal & Specialized Solutions and Advanced Performance Materials. Chemours also launched new refrigerant products for data centers and projects Q3 adjusted EBITDA between $175 million and $205 million, with full-year 2026 sales growth of 1% to 5%.
2026-08-10 22:46:06
Chemours Co's CFO, Shane Hostetter, recently purchased 3,350 shares of the company stock, signaling strong insider confidence. This transaction, executed at $14.94 per share, increases his direct ownership to over 102,000 shares. The stock is currently deemed "Modestly Undervalued" by GuruFocus's GF Value model, suggesting a potential attractive entry point for investors.
2026-08-10 21:46:06
Chemours (NYSE:CC) CFO Shane Hostetter recently purchased 3,350 shares of the company's stock for $50,049, increasing his holdings by 3.37%. This transaction occurred as Chemours reported quarterly adjusted EPS and revenue below analyst consensus, with shares trading near $14.52. Despite the earnings miss, analysts maintain a "Moderate Buy" rating with an average price target of $21.00, and the company has declared a quarterly dividend of $0.0875 per share.
2026-08-10 20:46:06
Chemours Co's Chief Financial Officer, Shane Hostetter, purchased 3,350 shares of common stock on August 6, 2026, at a price of $14.94 per share. This transaction increased his total beneficial ownership to 102,697.7058 shares, including restricted stock units and dividend equivalent units. The purchase was an open-market transaction and was not made under a Rule 10b5-1 trading plan.
